NCT02313597

Brief Summary

Anal fistula is the most common Peri anal disease. It's a disease with an incidence of 9 in 100,000. Anal fistula is classified on the basis of its location into high and low anal fistula, above or below dentate line respectively. Multiple series have shown that the formation of a fistula tract following anorectal abscess occurs in 7-40% of cases. There are typically 8-10 anal crypt glands at the level of the dentate line in the anal canal arranged circumstantially. These glands afford a path for infecting organisms to reach the intramuscular spaces. The cryptoglandular hypothesis states that an infection begins in the anal canal glands and progresses into the muscular wall of the anal sphincters to cause an anorectal abscess. According to internal opening many author proposed certain classification but the standardized in all of them is Park's classification, so this study categorized the patient through this classification. There are four types of fistula-in-ano in Park's Classification intersphincteric (between internal and external sphincters is 70%), transsphincteric (across external sphincters is 25%), suprasphincteric (over sphincters), and extrasphincteric(above and through levator ani).High anal fistula is considered to be difficult to treat because of its location.This study diagnosed the internal opening of high perianal with the help of endoluminal ultrasound and MRI. Classic method of its treatment are fistulotomy, fistulectomy and Setone placement but these are associated with lots of complication like fecal incontinence,recurrence,pain.Therefore many method have been recently devised including Ligation of intersphincteric fistula tract (Lift), glue repair and flap advancement.Another recently introduced method for its treatment is Video-assisted anal fistula treatment (VAAFT) proposed by P. Meinero which has been associated with less complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

August 28, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 10, 2014

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
6 months until next milestone

Results Posted

Study results publicly available

January 27, 2021

Completed
Last Updated

March 11, 2021

Status Verified

February 1, 2021

Enrollment Period

6 years

First QC Date

August 28, 2014

Results QC Date

November 28, 2020

Last Update Submit

February 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Recurrence of Disease or Fistula

    Number of Participants with Recurrence of Disease or Fistula 3 Years After Treatment

    3 years postoperatively

Secondary Outcomes (4)

  • Duration of Surgery

    Time from beginning of surgery to end of surgery,assessed up to 180 minutes

  • Pain Score

    12 hours after surgery

  • Time to Return to Work

    up to 4 weeks

  • Time to Healing of Fistula

    up to 12 weeks

Study Arms (2)

SETON

PLACEBO COMPARATOR

Silk suture will be used as SETON

Procedure: SETON

VAAFT

EXPERIMENTAL

Video assisted anal fistula treatment

Procedure: VAAFT

Interventions

SETONPROCEDURE

In seton treatment, initially Hydrogen peroxide will be applied to the external opening with a 10-cc syringe, and the internal opening will be located by direct visualization of the anal canal via proctoscope. A probe will be inserted into the external opening and carefully maneuvered through the internal opening. Silk 1/0 suture will be then tied to the tip of the probe, which will be then squeezed out of the external opening. The suture will be then tied around the sphincter and through fistula tract. Later, the seton will be tightened at four-week intervals under local anesthesia until the suture cut through the sphincter.

SETON
VAAFTPROCEDURE

Patients assigned to the VAAFT group will receive the following procedure. The external opening will be widened with a probe, and a fistulascope will be inserted to delineate the primary and secondary tracts and locate the internal opening. The internal opening will be then stitched with Vicrylâ„¢ (Polyglactin 910) 2-0 suture through the anal route with the help of a proctoscope. The tract of the fistula will be washed and debrided through the scope and cauterized. Finally, the external opening will be excised and will be sent for biopsy.

VAAFT

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients of either gender with age ranging from 15 to 60 years.
  • All patients with high anal fistula

You may not qualify if:

  • Patients with suspected malignancy determined by the presence of a mass on digital rectal examination,
  • History of previous perianal surgery,
  • History of irritable bowel disease determined by medical record
  • Uncontrolled diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospitals

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Pain, PostoperativeRecurrence

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsDisease Attributes

Limitations and Caveats

One of the limitations of our study is that it is single center study and results cannot be generalized, another thing is that we did not inject glue after doing VAAFT into remaining tract (as advised by Monre who is the inventor of this procedure) and we do not know whether this injection of glue can affect recurrence of fistula or not.

Results Point of Contact

Title
Dr, Shabbar Hussain Changazi
Organization
Services Institute of Medical Sciences

Study Officials

  • Mahmood Ayyaz, FCPS FACS

    Professor of Surgery

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Officer

Study Record Dates

First Submitted

August 28, 2014

First Posted

December 10, 2014

Study Start

August 1, 2014

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

March 11, 2021

Results First Posted

January 27, 2021

Record last verified: 2021-02

Locations